Literature DB >> 6311468

Increased expression of human monocyte HLA-DR antigens and Fc gamma receptors in response to human interferon in vivo.

J Rhodes, D H Jones, N M Bleehen.   

Abstract

The expression of class II MHC encoded antigens (HLA-DR) and Fc gamma receptors by peripheral blood monocytes from untreated patients with small cell carcinoma of the bronchus was compared with that of normal donors. Fc gamma receptor expression was found to be elevated in these patients in comparison with normal. In contrast HLA-DR antigen expression by patients' monocytes was somewhat depressed in comparison with normal. Continuous intravenous infusion of a total of 400 megaunits/m2 of human lymphoblastoid interferon-alpha (IFN-alpha) over a 5 day period markedly increased both monocyte HLA-DR antigen expression and Fc gamma receptor expression in comparison with that of untreated patients and normal donors. The initial increases declined somewhat but were still evident after 3 weeks of intermittent intramuscular IFN-alpha therapy.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6311468      PMCID: PMC1535636     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  19 in total

1.  Differential effect of interferon expression of IgG- and IgM-Fc receptors on human lymphocytes.

Authors:  K Itoh; M Inoue; S Kataoka; K Kumagai
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

2.  A monoclonal antibody to the HLA-DR product recognizes a polymorphic Ia determinant in mice.

Authors:  P M Brickell; I McConnell; C Milstein; B Wright
Journal:  Immunology       Date:  1981-07       Impact factor: 7.397

3.  Increased monocyte phagocytosis in cancer patients.

Authors:  L P Ruco; A Procopio; S Uccini; C D Baroni
Journal:  Eur J Cancer       Date:  1980-10       Impact factor: 9.162

4.  Enhanced expression of HLA antigens and beta 2-microglobulin on interferon-treated human lymphoid cells.

Authors:  M Fellous; M Kamoun; I Gresser; R Bono
Journal:  Eur J Immunol       Date:  1979-06       Impact factor: 5.532

5.  Isolation of an inhibitor of type II interferon induction from tumor ascitic fluids.

Authors:  S Matsubara; M Suzuki; M Nakamura; K Edo; N Ishida
Journal:  Cancer Res       Date:  1980-07       Impact factor: 12.701

6.  Impaired induction of type II interferon in tumor-bearing mice.

Authors:  S Matsubara; M Suzuki; N Ishida
Journal:  Cancer Res       Date:  1980-03       Impact factor: 12.701

7.  Retinoic acid: enhancement of a tumor and inhibition of interferon's antitumor action.

Authors:  S Baron; K M Kleyn; J K Russell; J E Blalock
Journal:  J Natl Cancer Inst       Date:  1981-07       Impact factor: 13.506

8.  Interferon-induced changes in the monocyte membrane: inhibition by retinol and retinoic acid.

Authors:  J Rhodes; P Stokes
Journal:  Immunology       Date:  1982-03       Impact factor: 7.397

9.  Interferon enhances the expression of Fc gamma receptors.

Authors:  W H Fridman; I Gresser; M T Bandu; M Aguet; C Neauport-Sautes
Journal:  J Immunol       Date:  1980-05       Impact factor: 5.422

10.  Interferon treatment of mice: enhanced expression of histocompatibility antigens on lymphoid cells.

Authors:  P Lindahl; I Gresser; P Leary; M Tovey
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

View more
  11 in total

1.  Depression of drug metabolizing activity in the human liver by interferon-alpha.

Authors:  H Okuno; Y Kitao; M Takasu; H Kano; K Kunieda; T Seki; Y Shiozaki; Y Sameshima
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Differing patterns of circulating regulatory T cells and myeloid-derived suppressor cells in metastatic melanoma patients receiving anti-CTLA4 antibody and interferon-α or TLR-9 agonist and GM-CSF with peptide vaccination.

Authors:  Ahmad A Tarhini; Lisa H Butterfield; Yongli Shuai; William E Gooding; Pawel Kalinski; John M Kirkwood
Journal:  J Immunother       Date:  2012 Nov-Dec       Impact factor: 4.456

3.  Human macrophage activation. Modulation of mannosyl, fucosyl receptor activity in vitro by lymphokines, gamma and alpha interferons, and dexamethasone.

Authors:  T Mokoena; S Gordon
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

4.  Incidence and severity of acute allograft rejection in liver transplant recipients treated with alfa interferon.

Authors:  A Jain; A J Demetris; R Manez; A C Tsamanadas; D Van Thiel; J Rakela; T E Starzl; J J Fung
Journal:  Liver Transpl Surg       Date:  1998-05

5.  Efficacy and safety of treatment of hepatitis C virus infection in renal transplant recipients.

Authors:  Abdulrahman A Aljumah; Mohamed A Saeed; Ahmed I Al Flaiw; Ibrahim H Al Traif; Abduljaleel M Al Alwan; Salem H Al Qurashi; Ghormallah A Al Ghamdi; Fayez F Al Hejaili; Mohammed A Al Balwi; Abdulla A Al Sayyari
Journal:  World J Gastroenterol       Date:  2012-01-07       Impact factor: 5.742

6.  Enhancement of monocyte class I and II histocompatibility antigen expression in man by in vivo beta-interferon.

Authors:  G T Spear; D M Paulnock; R L Jordan; D M Meltzer; J A Merritt; E C Borden
Journal:  Clin Exp Immunol       Date:  1987-07       Impact factor: 4.330

7.  Serum cytokines associated with severity and complications of kala-azar.

Authors:  Dorcas L Costa; Regina L Rocha; Rayssa M A Carvalho; Adelino S Lima-Neto; Michael O Harhay; Carlos Henrique N Costa; Manoel Barral-Neto; Aldina P Barral
Journal:  Pathog Glob Health       Date:  2013-03       Impact factor: 2.894

8.  Human tumour-induced inhibition of interferon action in vitro: reversal of inhibition by beta-carotene (pro-vitamin A).

Authors:  J Rhodes; P Stokes; P Abrams
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

9.  The primary mediastinal clear cell lymphoma of B-cell type has variable defects in MHC antigen expression.

Authors:  P Möller; B Lämmler; B Herrmann; H F Otto; G Moldenhauer; F Momburg
Journal:  Immunology       Date:  1986-11       Impact factor: 7.397

10.  Administration of recombinant interferon gamma to cancer patients enhances monocyte secretion of hydrogen peroxide.

Authors:  C F Nathan; C R Horowitz; J de la Harpe; S Vadhan-Raj; S A Sherwin; H F Oettgen; S E Krown
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.